Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CLOTRIMAZOLE/MICONAZOLE SWITCH TO NONPRESCRIPTION STATUS IN CANADA

This article was originally published in The Tan Sheet

Executive Summary

CLOTRIMAZOLE/MICONAZOLE SWITCH TO NONPRESCRIPTION STATUS IN CANADA will become official on Sept. 1. Canadian Bureau of Nonprescription Drugs Director Mary Carman, PharmD, speaking at a June 8 session of the Drug Information Association's annual meeting noted, however, that Canada's decision to switch miconazole and clotrimazole to nonprescription status "does not parallel the decision in the U.S." because the two antifungals "will be permitted OTC in seven-day, three-day and one-day therapies." Only seven-day therapy is allowed with miconazole and clotrimazole in the U.S. for vaginal yeast infections.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel